The Non-Coding RNA Landscape of Plasma Cell Dyscrasias

Despite substantial advancements have been done in the understanding of the pathogenesis of plasma cell (PC) disorders, these malignancies remain hard-to-treat. The discovery and subsequent characterization of non-coding transcripts, which include several members with diverse length and mode of acti...

Full description

Bibliographic Details
Main Authors: Eugenio Morelli, Annamaria Gullà, Roberta Rocca, Cinzia Federico, Lavinia Raimondi, Stefano Malvestiti, Valter Agosti, Marco Rossi, Giosuè Costa, Gianluca Giavaresi, Abdel Kareem Azab, Antonia Cagnetta, Michele Cea, Pierosandro Tagliaferri, Antonino Neri, Nikhil C. Munshi, Giuseppe Viglietto, Pierfrancesco Tassone, Nicola Amodio
Format: Article
Language:English
Published: MDPI AG 2020-01-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/2/320
_version_ 1797764978275516416
author Eugenio Morelli
Annamaria Gullà
Roberta Rocca
Cinzia Federico
Lavinia Raimondi
Stefano Malvestiti
Valter Agosti
Marco Rossi
Giosuè Costa
Gianluca Giavaresi
Abdel Kareem Azab
Antonia Cagnetta
Michele Cea
Pierosandro Tagliaferri
Antonino Neri
Nikhil C. Munshi
Giuseppe Viglietto
Pierfrancesco Tassone
Nicola Amodio
author_facet Eugenio Morelli
Annamaria Gullà
Roberta Rocca
Cinzia Federico
Lavinia Raimondi
Stefano Malvestiti
Valter Agosti
Marco Rossi
Giosuè Costa
Gianluca Giavaresi
Abdel Kareem Azab
Antonia Cagnetta
Michele Cea
Pierosandro Tagliaferri
Antonino Neri
Nikhil C. Munshi
Giuseppe Viglietto
Pierfrancesco Tassone
Nicola Amodio
author_sort Eugenio Morelli
collection DOAJ
description Despite substantial advancements have been done in the understanding of the pathogenesis of plasma cell (PC) disorders, these malignancies remain hard-to-treat. The discovery and subsequent characterization of non-coding transcripts, which include several members with diverse length and mode of action, has unraveled novel mechanisms of gene expression regulation often malfunctioning in cancer. Increasing evidence indicates that such non-coding molecules also feature in the pathobiology of PC dyscrasias, where they are endowed with strong therapeutic and/or prognostic potential. In this review, we aim to summarize the most relevant findings on the biological and clinical features of the non-coding RNA landscape of malignant PCs, with major focus on multiple myeloma. The most relevant classes of non-coding RNAs will be examined, along with the mechanisms accounting for their dysregulation and the recent strategies used for their targeting in PC dyscrasias. It is hoped these insights may lead to clinical applications of non-coding RNA molecules as biomarkers or therapeutic targets/agents in the near future.
first_indexed 2024-03-12T20:03:27Z
format Article
id doaj.art-118afff3c4794c35b8c90a74376c383f
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-12T20:03:27Z
publishDate 2020-01-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-118afff3c4794c35b8c90a74376c383f2023-08-02T02:14:32ZengMDPI AGCancers2072-66942020-01-0112232010.3390/cancers12020320cancers12020320The Non-Coding RNA Landscape of Plasma Cell DyscrasiasEugenio Morelli0Annamaria Gullà1Roberta Rocca2Cinzia Federico3Lavinia Raimondi4Stefano Malvestiti5Valter Agosti6Marco Rossi7Giosuè Costa8Gianluca Giavaresi9Abdel Kareem Azab10Antonia Cagnetta11Michele Cea12Pierosandro Tagliaferri13Antonino Neri14Nikhil C. Munshi15Giuseppe Viglietto16Pierfrancesco Tassone17Nicola Amodio18Dana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USADana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USADepartment of Experimental and Clinical Medicine, <i>Magna Graecia</i> University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USAIRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyDana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USADepartment of Experimental and Clinical Medicine, <i>Magna Graecia</i> University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Experimental and Clinical Medicine, <i>Magna Graecia</i> University of Catanzaro, 88100 Catanzaro, ItalyNet4Science srl, <i>Magna Graecia</i> University of Catanzaro, 88100 Catanzaro, ItalyIRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, ItalyDepartment of Radiation Oncology, Cancer Biology Division, Washington University in St. Louis School of Medicine, St. Louis, MO 63108, USAIRCCS, Ospedale Policlinico San Martino, 16100 Genoa, ItalyIRCCS, Ospedale Policlinico San Martino, 16100 Genoa, ItalyDepartment of Experimental and Clinical Medicine, <i>Magna Graecia</i> University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Oncology and Hemato-oncology, University of Milan and Hematology, Fondazione Cà Granda IRCCS Policlinico, 20122 Milan, ItalyDana Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USADepartment of Experimental and Clinical Medicine, <i>Magna Graecia</i> University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Experimental and Clinical Medicine, <i>Magna Graecia</i> University of Catanzaro, 88100 Catanzaro, ItalyDepartment of Experimental and Clinical Medicine, <i>Magna Graecia</i> University of Catanzaro, 88100 Catanzaro, ItalyDespite substantial advancements have been done in the understanding of the pathogenesis of plasma cell (PC) disorders, these malignancies remain hard-to-treat. The discovery and subsequent characterization of non-coding transcripts, which include several members with diverse length and mode of action, has unraveled novel mechanisms of gene expression regulation often malfunctioning in cancer. Increasing evidence indicates that such non-coding molecules also feature in the pathobiology of PC dyscrasias, where they are endowed with strong therapeutic and/or prognostic potential. In this review, we aim to summarize the most relevant findings on the biological and clinical features of the non-coding RNA landscape of malignant PCs, with major focus on multiple myeloma. The most relevant classes of non-coding RNAs will be examined, along with the mechanisms accounting for their dysregulation and the recent strategies used for their targeting in PC dyscrasias. It is hoped these insights may lead to clinical applications of non-coding RNA molecules as biomarkers or therapeutic targets/agents in the near future.https://www.mdpi.com/2072-6694/12/2/320multiple myelomanon-coding rnaplasma cell dyscrasiamirnalncrna
spellingShingle Eugenio Morelli
Annamaria Gullà
Roberta Rocca
Cinzia Federico
Lavinia Raimondi
Stefano Malvestiti
Valter Agosti
Marco Rossi
Giosuè Costa
Gianluca Giavaresi
Abdel Kareem Azab
Antonia Cagnetta
Michele Cea
Pierosandro Tagliaferri
Antonino Neri
Nikhil C. Munshi
Giuseppe Viglietto
Pierfrancesco Tassone
Nicola Amodio
The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
Cancers
multiple myeloma
non-coding rna
plasma cell dyscrasia
mirna
lncrna
title The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
title_full The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
title_fullStr The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
title_full_unstemmed The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
title_short The Non-Coding RNA Landscape of Plasma Cell Dyscrasias
title_sort non coding rna landscape of plasma cell dyscrasias
topic multiple myeloma
non-coding rna
plasma cell dyscrasia
mirna
lncrna
url https://www.mdpi.com/2072-6694/12/2/320
work_keys_str_mv AT eugeniomorelli thenoncodingrnalandscapeofplasmacelldyscrasias
AT annamariagulla thenoncodingrnalandscapeofplasmacelldyscrasias
AT robertarocca thenoncodingrnalandscapeofplasmacelldyscrasias
AT cinziafederico thenoncodingrnalandscapeofplasmacelldyscrasias
AT laviniaraimondi thenoncodingrnalandscapeofplasmacelldyscrasias
AT stefanomalvestiti thenoncodingrnalandscapeofplasmacelldyscrasias
AT valteragosti thenoncodingrnalandscapeofplasmacelldyscrasias
AT marcorossi thenoncodingrnalandscapeofplasmacelldyscrasias
AT giosuecosta thenoncodingrnalandscapeofplasmacelldyscrasias
AT gianlucagiavaresi thenoncodingrnalandscapeofplasmacelldyscrasias
AT abdelkareemazab thenoncodingrnalandscapeofplasmacelldyscrasias
AT antoniacagnetta thenoncodingrnalandscapeofplasmacelldyscrasias
AT michelecea thenoncodingrnalandscapeofplasmacelldyscrasias
AT pierosandrotagliaferri thenoncodingrnalandscapeofplasmacelldyscrasias
AT antoninoneri thenoncodingrnalandscapeofplasmacelldyscrasias
AT nikhilcmunshi thenoncodingrnalandscapeofplasmacelldyscrasias
AT giuseppeviglietto thenoncodingrnalandscapeofplasmacelldyscrasias
AT pierfrancescotassone thenoncodingrnalandscapeofplasmacelldyscrasias
AT nicolaamodio thenoncodingrnalandscapeofplasmacelldyscrasias
AT eugeniomorelli noncodingrnalandscapeofplasmacelldyscrasias
AT annamariagulla noncodingrnalandscapeofplasmacelldyscrasias
AT robertarocca noncodingrnalandscapeofplasmacelldyscrasias
AT cinziafederico noncodingrnalandscapeofplasmacelldyscrasias
AT laviniaraimondi noncodingrnalandscapeofplasmacelldyscrasias
AT stefanomalvestiti noncodingrnalandscapeofplasmacelldyscrasias
AT valteragosti noncodingrnalandscapeofplasmacelldyscrasias
AT marcorossi noncodingrnalandscapeofplasmacelldyscrasias
AT giosuecosta noncodingrnalandscapeofplasmacelldyscrasias
AT gianlucagiavaresi noncodingrnalandscapeofplasmacelldyscrasias
AT abdelkareemazab noncodingrnalandscapeofplasmacelldyscrasias
AT antoniacagnetta noncodingrnalandscapeofplasmacelldyscrasias
AT michelecea noncodingrnalandscapeofplasmacelldyscrasias
AT pierosandrotagliaferri noncodingrnalandscapeofplasmacelldyscrasias
AT antoninoneri noncodingrnalandscapeofplasmacelldyscrasias
AT nikhilcmunshi noncodingrnalandscapeofplasmacelldyscrasias
AT giuseppeviglietto noncodingrnalandscapeofplasmacelldyscrasias
AT pierfrancescotassone noncodingrnalandscapeofplasmacelldyscrasias
AT nicolaamodio noncodingrnalandscapeofplasmacelldyscrasias